Evidence map›Paper›PMID 25861024›Full record

ArticlePloS one2015

Induction of microglia activation after infection with the non-neurotropic A/CA/04/2009 H1N1 influenza virus.

Shankar Sadasivan, Mark Zanin, Kevin O'Brien, Stacey Schultz-Cherry, Richard J Smeyne

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Virally-initiated pain states: phenotypes, mechanisms, and future directions.Frontiers in pain research (Lausanne, Switzerland) · 2025
    Article
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shankar SadasivanDepartment of Developmental Neurobiology, Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States of America.
Mark ZaninDepartment of Infectious Diseases, Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States of America.
Kevin O'BrienDepartment of Infectious Diseases, Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States of America.
Stacey Schultz-CherryDepartment of Infectious Diseases, Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States of America.
Richard J SmeyneDepartment of Developmental Neurobiology, Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States of America.

Funding

Influenza, Inflammation, and Parkinson's DiseaseR01NS075840 · NINDS · THOMAS JEFFERSON UNIVERSITY · PI SMEYNE, RICHARD J · 2012 to 2016
$1.9M
NINDS NIH HHS NS075840-01NINDS NIH HHS R01 NS075840
6 · The paper itself

Abstract

Although influenza is primarily a respiratory disease, it has been shown, in some cases, to induce encephalitis, including people acutely infected with the pandemic A/California/04/2009 (CA/09) H1N1 virus. Based on previous studies showing that the highly pathogenic avian influenza (HPAI) A/Vietnam/1203/2004 H5N1 virus was neurotropic, induced CNS inflammation and a transient parkinsonism, we examined the neurotropic and inflammatory potential of the CA/09 H1N1 virus in mice. Following intranasal inoculation, we found no evidence for CA/09 H1N1 virus neurotropism in the enteric, peripheral or central nervous systems. We did, however, observe a robust increase in microglial activity in the brain characterized by an increase in the number of activated Iba-1-positive microglia in the substantia nigra (SN) and the hippocampus, despite the absence of virus in the brain. qPCR analysis in SN tissue showed that the induction of microgliosis was preceded by reduced gene expression of the neurotrophic factors bdnf, and gdnf and increases in the immune modulatory chemokine chemokine (C-C motif) ligand 4 (ccl4). We also noted changes in the expression of transforming growth factor-1 (tgfβ1) in the SN starting at 7 days post-infection (dpi) that was sustained through 21 dpi, coupled with increases in arginase-1 (arg1) and csf1, M2 markers for microglia. Given that neuroinflammation contributes to generation and progression of a number of neurodegenerative disorders, these findings have significant implications as they highlight the possibility that influenza and perhaps other non-neurotropic viruses can initiate inflammatory signals via microglia activation in the brain and contribute to, but not necessarily be the primary cause of, neurodegenerative disorders.

Indexed as

AnimalsArginaseBlood-Brain BarrierChemokinesDentate GyrusEncephalitisFemaleGene ExpressionInfluenza A Virus, H1N1 SubtypeMiceMice, Inbred C57BLMicrogliaNerve Growth FactorsOrthomyxoviridae InfectionsPars CompactaReceptors, Granulocyte-Macrophage Colony-Stimulating FactorArg1 protein, mouseArginaseChemokinesCsf1r protein, mouseNerve Growth FactorsReceptors, Granulocyte-Macrophage Colony-Stimulating FactorTransforming Growth Factor beta1

Identifiers

PMID25861024
PMCPMC4393251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.